JinJiang ablation catheter is no inferior than Johnson ablation catheter in radiofrequency ablation of paroxysmal supraventricular tachycardia
© 2023 Wiley Periodicals LLC..
BACKGROUND: Paroxysmal supraventricular tachycardia (PSVT) is characterized by episodes of rapid tachycardia with sudden onset and sudden termination. PSVT treatment has evolved considerably over the past 30 years. Currently, radiofrequency catheter ablation is the first-line treatment.
HYPOTHESIS: We conducted a randomized controlled trial to compare safety and effectiveness of PSVT ablation between the Jinjiang and Johnson (J&J) catheters in 57 patients in our hospital.
METHODS AND RESULTS: Patients were randomly assigned to ablation procedures using either the Jinjiang system or the J&J Carto system. Follow-up was performed 3 days, 1, and 6 months after the procedure. Success rate, ablation time, frequency of ablation, and rates of complications and recurrence did not significantly differ between the groups. One Jinjiang group patient (3.6%) experienced arrhythmia recurrence during the 6-month follow-up.
CONCLUSIONS: The Jinjiang catheter for radiofrequency ablation of PSVT is as safe and effective as the J&J catheter.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:47 |
|---|---|
| Enthalten in: |
Pacing and clinical electrophysiology : PACE - 47(2024), 2 vom: 07. Feb., Seite 275-280 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Li, Ying [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Arrhythmia |
|---|
| Anmerkungen: |
Date Completed 15.02.2024 Date Revised 20.03.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1111/pace.14898 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM365505390 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM365505390 | ||
| 003 | DE-627 | ||
| 005 | 20240321235705.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/pace.14898 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1338.xml |
| 035 | |a (DE-627)NLM365505390 | ||
| 035 | |a (NLM)38059637 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Li, Ying |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a JinJiang ablation catheter is no inferior than Johnson ablation catheter in radiofrequency ablation of paroxysmal supraventricular tachycardia |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 15.02.2024 | ||
| 500 | |a Date Revised 20.03.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2023 Wiley Periodicals LLC. | ||
| 520 | |a BACKGROUND: Paroxysmal supraventricular tachycardia (PSVT) is characterized by episodes of rapid tachycardia with sudden onset and sudden termination. PSVT treatment has evolved considerably over the past 30 years. Currently, radiofrequency catheter ablation is the first-line treatment | ||
| 520 | |a HYPOTHESIS: We conducted a randomized controlled trial to compare safety and effectiveness of PSVT ablation between the Jinjiang and Johnson (J&J) catheters in 57 patients in our hospital | ||
| 520 | |a METHODS AND RESULTS: Patients were randomly assigned to ablation procedures using either the Jinjiang system or the J&J Carto system. Follow-up was performed 3 days, 1, and 6 months after the procedure. Success rate, ablation time, frequency of ablation, and rates of complications and recurrence did not significantly differ between the groups. One Jinjiang group patient (3.6%) experienced arrhythmia recurrence during the 6-month follow-up | ||
| 520 | |a CONCLUSIONS: The Jinjiang catheter for radiofrequency ablation of PSVT is as safe and effective as the J&J catheter | ||
| 650 | 4 | |a Randomized Controlled Trial | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a arrhythmia | |
| 650 | 4 | |a radiofrequency ablation | |
| 650 | 4 | |a supraventricular tachycardia | |
| 700 | 1 | |a Xiong, Ganwei |e verfasserin |4 aut | |
| 700 | 1 | |a Liu, Yuan |e verfasserin |4 aut | |
| 700 | 1 | |a Huang, Xiantao |e verfasserin |4 aut | |
| 700 | 1 | |a Liu, Yanfeng |e verfasserin |4 aut | |
| 700 | 1 | |a Zhou, Haiwen |e verfasserin |4 aut | |
| 700 | 1 | |a Xu, Zhicheng |e verfasserin |4 aut | |
| 700 | 1 | |a Tao, Yu |e verfasserin |4 aut | |
| 700 | 1 | |a Zhang, Fanzhi |e verfasserin |4 aut | |
| 700 | 1 | |a Lai, Hengli |e verfasserin |4 aut | |
| 700 | 1 | |a Chen, Zhenhuan |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Pacing and clinical electrophysiology : PACE |d 1983 |g 47(2024), 2 vom: 07. Feb., Seite 275-280 |w (DE-627)NLM000837431 |x 1540-8159 |7 nnns |
| 773 | 1 | 8 | |g volume:47 |g year:2024 |g number:2 |g day:07 |g month:02 |g pages:275-280 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1111/pace.14898 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 47 |j 2024 |e 2 |b 07 |c 02 |h 275-280 | ||